How to Transport Medical Marijuana Abroad? Guide 2026

The most common mistake when planning a trip with a cannabis medicine is assuming that transport rules follow possession rules. In several countries covered by this review, the opposite is true: importation is punishable, while possession of the same substance locally is not.

Below are ten legal frameworks for which we have measured status in this field, arranged not alphabetically but according to the type of trap a traveler might fall into.

Why does transport follow different rules than possession?

The state border is a separate event in drug law, not just a background for possession. The same material transported across it usually falls under a different regulation than the one describing its storage, and sometimes this regulation turns out to be much stricter.

The clearest example is the United Kingdom. The local Psychoactive Substances Act punishes intentional import even when the carrier intends to use the item solely for themselves.

The result is paradoxical and worth remembering. Importing is punishable, while possession of the same material locally is not, so the entire sanction lies in the single moment of crossing the border.

The law also sets a lower threshold of awareness than for possession. It is enough that the perpetrator knows or suspects, or should know or suspect, that the substance is psychoactive, so ignorance does not protect as it usually does.

The practical conclusion is one and applies throughout this review. Legal purchase in another country does not protect upon entry, and the national status checked in our marijuana legality map does not answer the question about transport.

Which countries have a clear procedure for patients with medicine?

Three countries in this review have described a procedure for patients specifically, with numbers and required documents. This is the best situation a traveler can find themselves in, as conditions can be met before departure and checked independently without relying on the controller’s discretion.

The most quantifiable procedure is in Montenegro. A person crossing the border may possess medicine containing narcotics in an amount needed for their own therapy, for a period of up to thirty days, based on a certificate from a chosen doctor or a mental health specialist.

Montenegro also considered a situation most regulations omit. Similarly, one may carry medicine for an animal traveling with the owner, based on a veterinary certificate, and failure to declare such a document is a separate offense there with a 100 euro fine.

Two formal conditions are as important as the document itself. The document loses validity 90 days after issuance, and at the border, it must be voluntarily shown to customs.

Thailand operates similarly, but with a division into two categories of medicines. If the medicine is not a controlled substance, the patient in treatment may transport an amount not exceeding thirty days of prescribed use; if it contains narcotics or psychotropic substances, a separate permit is required, which must be applied for in advance.

Where does crossing the border itself increase liability?

The second group includes countries where crossing the border itself elevates the act to a higher category, even for amounts considered minor domestically. Lithuania is the clearest and most instructive example for someone traveling in Europe by their own car. The difference there can be greater than the driver expects.

The Lithuanian code has a separate smuggling offense starting from a small amount. It is enough to bypass customs control, avoid it in another way, or lack a permit and transport or send a small amount of narcotics across the border without intent to distribute.

Sanctions range from fines through restriction of liberty and detention up to two years imprisonment. The key comparison is with the domestic situation: the same amount stored locally is a misdemeanor, with imprisonment removed from the penalty catalog.

Postal shipments do not provide any relief compared to baggage transport. The regulation lists both forms side by side, so ordering from abroad is not a milder version of personally carrying the same amount in baggage.

Italy falls into the same group, though by a different mechanism. An administrative sanction there includes suspension of travel documents, directly affecting the ability to travel, not possession itself.

Which countries prosecute acts committed outside their territory?

The third group is the most surprising in this review, as it covers acts committed entirely elsewhere than in the prosecuting country. Two states reach beyond their territory but do so in two different ways and towards two different groups of people.

Singapore prosecutes use outside its territory. A Singaporean or permanent resident detected using a controlled substance abroad is liable as if they used it locally.

The effect is clear and worth stating plainly. Legal use in a country where it is allowed does not protect a Singapore resident upon return, as the place of the act does not matter for this liability.

Indonesia acts oppositely, targeting foreigners at entry. A foreigner who served a drug offense sentence there is subject to deportation, and the return route is closed.

The third paragraph of this regulation goes further. A foreigner who ever committed a drug offense abroad is banned from entering Indonesia, so a past conviction, even from a country where cannabis is now legal, can permanently close this route.

What does it mean that transport goes exclusively through official channels?

The fourth situation is not a ban but a lack of a provided route, and that is why it is easiest to overlook when planning travel. It concerns countries where medical cannabis transport is reserved for an office, so the patient has no procedure they can use independently. There is also no one to apply to.

This is the case in the Netherlands. The local medical cannabis office has a monopoly on import and export, so transport outside this office’s channel is not foreseen at all.

Silence of the regulation is not the same as a ban, and this difference must be maintained. Dutch law does not explicitly take anything away from the patient; it simply does not foresee a situation where the patient carries medicine themselves.

Portugal solved this differently, covering these activities with an executive regulation. The 2019 act covers possession and transport as well as import, export, and transit of cannabis preparations for medical purposes.

The Emirates stand apart, where classification is customs-based, not medical. Narcotics, psychotropics, and other controlled medicines of class A or B are controlled goods there, and some medicines require a Ministry of Health permit applied for before travel.

How to prepare for travel with cannabis medicine?

The first rule is that transport must be asked about separately, not inferred from possession status. In this review, we have a country where import is punishable but possession is not, and a country where possession is a misdemeanor but transport is a crime.

The second rule concerns documents and deadlines. Where a patient procedure exists, it is based on a doctor’s certificate, has a limit counted in days of therapy, not grams, and is often bound by document validity dates.

The third rule concerns timing. Permits mentioned in Thailand and the Emirates are obtained before travel, not at the airport, so lack of a document is revealed only when nothing can be done.

The fourth rule is the hardest to accept. A criminal record from years ago may matter more in travel planning than anything in the luggage, applying both to entry to Indonesia and return to Singapore.

The fifth rule organizes all previous ones. The status of the destination country, transit country, and return country must be checked separately, as each of these three stages may be regulated by different rules.

The travel process itself is described separately. Who decides what at check-in, transfer, and inspection is collected in the text about what happens to cannabis medicine at the airport.

Which document allows legal export of medicine from Poland?

A document enabling transport of a narcotic, psychotropic substance, or category 1 precursor for personal medical needs. It is issued by the pharmaceutical inspection authority upon request of the person taking the medicinal product. The basis is paragraphs 5 and 6 of the Minister of Health regulation from June 8, 2026 (Journal of Laws 2026 item 827).

The regulation was issued based on article 37 paragraph 12 of the Act on Counteracting Drug Addiction, published June 23, 2026, and came into force July 12, 2026. On the same day, the Minister of Health regulation from March 16, 2017, which many guides still refer to, lost validity. Documents issued before the change remain valid, so a patient holding a paper from before July does not need to apply for a new one.

The document’s name is sometimes colloquially replaced by “certificate” in guides, which is not an error itself, as the construction derives from the certificate provided in article 75 of the Schengen Implementing Convention. More important is to use the proper legal basis when applying and to reach the correct authority, as this determines whether the case will proceed on time.

How does a patient document differ from a company permit?

In everything except that they are described by one regulation. Import and export permits concern business entities conducting trade, while the document from paragraphs 5 and 6 concerns a natural person transporting medicine for their own medical needs. Confusing these paths leads to an application submitted in the wrong procedure and loss of time, which is critical with a 15-day deadline.

The differences are measurable and visible in the act’s text. Permits for entities are issued by the Chief Pharmaceutical Inspector on green paper, in paper form prepared in Polish and English, and are valid for six months from issuance. They authorize a one-time crossing of the border with the substances covered. The import permit is issued in three copies, the export permit in four, with copies going to customs, the relevant authorities of the other country, and the holder.

Additionally, there are obligations the patient does not have at all. Applications for permits are submitted separately for narcotics and psychotropic substances, and one application can cover up to six items. The permit holder returns copies with confirmation to the authority within 14 days of confirmation, and if transport did not occur, returns all copies with a note of non-implementation. They also keep records for five years. None of this burdens a person traveling on vacation with their own medicine and should not appear in a patient guide.

How does the document from the provincial inspector differ from the one from GIF?

They differ by issuing authority and travel direction, but deadlines are identical. Paragraph 5 covers intra-community delivery, i.e., movement within the European Union, and paragraph 6 covers import or export, i.e., movement outside its borders. This distinction decides where to submit the application.

The difference in attachments results from the different construction of both provisions. Paragraph 5 refers to instructions specified in the Executive Committee decision from December 22, 1994, which sets the data scope. Paragraph 6 lists the required attachment directly in the provision: a prescription or medical documentation concerning the use of the medicinal product. In both cases, it is worth taking originals of these documents on the trip alongside the transport document itself.

Determining the correct procedure is the first step in the whole process, not a formality at the end. It is decided by the travel direction, not residence or carrier. A route with a transfer outside the EU or a stay in a third country complicates this assessment, so resolve doubts before applying by contacting the authority, not after receiving the document.

What changed with the regulation effective from July 12, 2026?

It replaced the 2017 act, which is why older guides are misleading today. Paragraph 12 of the new regulation repeals the Minister of Health regulation from March 16, 2017, on detailed conditions and procedures for issuing permits and documents necessary for import, export, intra-community acquisition, or intra-community delivery, published in the consolidated text from 2021.

Transitional provisions resolve two situations where a patient might be mid-procedure. Proceedings initiated and not completed before July 12, 2026, continue under previous rules. Documents issued before that date remain valid, so papers obtained earlier do not require replacement or reapplication if within their validity period.

The practical conclusion concerns source verification. If an online text refers to the 2017 regulation or gives deadlines other than 30 days validity and 15 days for application, it describes the pre-July 2026 state and should not be followed. The Journal of Laws item number and effective date can be checked independently in the ELI database, without intermediaries or accounts, and this is the fastest way to distinguish current from outdated procedure descriptions.

What does the document look like and what is worth checking in it?

The patient document issued under paragraph 6 is printed on pink paper with security features provided for third-category public paper documents. The template is appendix no. 3 to the regulation, and the document template for intra-community delivery is appendix no. 4. This means the form is established top-down and recognizable to authorities.

The electronic copy of the document remains with the issuing authority. For the patient, this means two things. First, during travel, they have a paper copy to show at inspection; a photo on a phone does not serve this function. Second, if the document is lost, the contact point is the issuing authority, as they hold the copy.

Before putting the document in carry-on luggage, check data consistency with the actual travel plan. The name and surname and identity document data must match the passport or ID used at the border. The preparation name and quantity must correspond to what is actually carried, and the document validity period must cover the entire trip, including the return day. Discrepancies in any of these points are easy for inspectors to detect and hard to explain on the spot, and can only be corrected by the issuing authority before departure.

Why is a prescription alone not enough at the border?

Because a prescription entitles purchase of medicine at a pharmacy, not transport of a narcotic across a state border. These are two different rights arising from two different regulations. The transport document function is fulfilled only by the document described in paragraphs 5 and 6 of the June 8, 2026 regulation, and the prescription is one of the attachments to the application for it.

The construction derives from international law. Article 75 of the Schengen Implementing Convention allows persons to transport narcotics and psychotropic substances necessary for their treatment, provided they show a certificate issued or authenticated by the competent authorities of the state of residence at inspection. The form and content of the certificate are specified by the Executive Committee decision from December 22, 1994, especially regarding the type and quantity of substances transported and the duration of the trip.

The Polish regulation is precisely an act serving the application of this decision, as stated in its notes. Paragraph 5 mandates issuing the document according to the instructions for the certificate from article 75. For the patient, this means a practical matter: the document has an established, recognizable form, and border services check its presence and correctness, not the legitimacy of treatment. Discussion about symptoms or therapy effectiveness is not needed at this point and cannot replace it. More about what papers a patient should carry daily is collected in the post about police control and medical marijuana.

How much medicine can be taken and for what period?

The document is issued for a specified period, no longer than 30 days. This limit concerns the document’s validity period and sets the planning boundary. The amount of medicine entered corresponds to this period and dosing from the prescription or medical documentation, not an arbitrarily chosen reserve.

The Executive Committee decision referenced in paragraph 5 lists among the certificate data the type and quantity of products transported and the trip duration. This means the amount is not entered arbitrarily but derived from dosing and trip length. Taking more than the document states places the patient outside its protection, even if the document is valid and correctly filled.

The consequence for longer trips is clear. Trips exceeding 30 days cannot be covered by a larger supply, as the limit concerns the document, not the medicine stock. One must plan treatment continuation locally or, in agreement with the attending physician, a therapy break during the trip. A third option, applying for another document during the stay abroad, is not realistic, as the application must be submitted before crossing the border. This part of the plan should be discussed with the doctor before booking, not after.

How is the transported preparation described in documents?

By name and quantity, and for cannabis flower additionally by THC content. For the patient document, the data scope is set by the Executive Committee decision from December 22, 1994, listing the type and quantity of products transported and trip duration. The regulation shows how the Polish legislator understands such a preparation description.

In regulations on permits for business entities, the description includes the pure narcotic name and its quantity in grams. If the traded item is a medicinal product, the number of packages, dose, pharmaceutical form, and GTIN number (if assigned) are added. For cannabis herb other than fiber and for pharmaceutical extracts and tinctures, THC content is also given, and for extracts, the amount of herb used to produce them. These are not patient obligations but show which preparation features the law considers essential.

For travelers, the practical tip is to describe the preparation as named on the prescription and pharmacy label, without abbreviations or colloquial names. The trade name, form, strength, and number of packages should match between prescription, transport document, and actual luggage contents. Controlled substance nomenclature is based on lists published by the International Narcotics Control Board and national regulations issued under the Act on Counteracting Drug Addiction, so it is not a matter of pharmacy discretion or habit.

How to schedule deadlines before departure?

From the end, i.e., the border crossing date. The regulation sets one hard condition: the application must be submitted no later than 15 days before that day. At the same time, the document is issued for a maximum of 30 days, so it cannot be obtained arbitrarily early and put away for the next season.

These two deadlines create a narrow window, which must also include a doctor’s visit and obtaining a prescription or medical documentation. The list below arranges tasks in reverse calendar order, as this is the easiest way to check if the plan fits.

The most common reason for a failed plan is banal: the patient starts the procedure after buying the ticket, not before. The 15-day deadline is strict, and the doctor’s visit and document issuance also take time. If the matter is urgent, it is wiser to postpone the trip than start without a document. If you are just beginning treatment, we described separately how to become a medical marijuana patient in Poland.

The list below works like a countdown, not a calendar. It starts from the departure day and goes back to the day you must schedule a doctor’s appointment, as only this way can you see if the application deadline still fits.

• Set the border crossing date and return date and count how many days of treatment the trip will cover.
• Check if the trip fits within 30 days, and if not, arrange a plan with the doctor for the remaining period.
• Visit the attending physician and secure a prescription or medical documentation concerning the preparation use.
• Determine whether the relevant authority is the provincial pharmaceutical inspector or the Chief Pharmaceutical Inspector.
• Submit the application no later than the fifteenth day before departure, allowing time for supplements.
• Collect the document, check the consistency of personal data, preparation name, and period with the actual travel plan.

What does the document handle and what does it not?

It handles the Polish side of border crossing and provides a basis for showing at inspection. It does not replace the law of the destination or transit country. This distinction is the most important single finding of this text and the source of most troubles patients face. The mechanism from article 75 operates between states that apply it and only covers transport of medicine necessary for treatment.

It does not regulate where the medicine may be used, whether driving after it is allowed, or if it can be transported further to another country. These issues are decided by local law, which may be completely different from Polish law and changes independently of our regulations.

Outside the area where the article 75 mechanism applies, the situation is different. The Polish document from paragraph 6 concerns export from Poland, while import of medicine to a third country depends solely on that country’s decision and usually requires its own import permit. Two consents issued by two different authorities are the rule, not the exception. Planning only one side of this pair is the most common mistake in long-distance travel. We maintain a separate post about the marijuana legality map showing where cannabis has medicine status worldwide.

How to check regulations of the destination and transit countries?

At the source, i.e., at the embassy or consulate of the destination country and its drug regulatory authority. No Polish document, guide, or travel agency hotline can replace this information, as only the destination country is bound by its own answer. It is worth doing this in writing and keeping correspondence.

Three things must be checked separately, as they may be regulated separately. First is the import of a THC-containing preparation for personal medical use, second is the required permit and its timing, third is the legal status in the transit country. The last is often overlooked. Do not assume that staying in the airport transit zone is legally neutral, as customs regulations of the transit country may also cover passenger baggage that does not leave the airport. Only that country can answer this question.

One must also be prepared for a negative answer. In some countries, possession of any amount of THC is a crime punishable by imprisonment, and a document issued by another country does not exclude liability there. The risk then is not a matter of careful document preparation but of the entry itself, and the wisest reaction is to change the route or give up transport. Warnings for travelers are published by the Polish Ministry of Foreign Affairs, and information about the transport procedure by the Chief Pharmaceutical Inspectorate.

What are the consequences of transport without the required document?

In Poland, criminal liability under article 62 of the Act on Counteracting Drug Addiction, consolidated text published in Journal of Laws 2023 item 1939. The basic type is punishable by imprisonment up to 3 years. The qualified type, concerning a significant amount, is punishable by 1 to 10 years imprisonment, and the lower limit determines the case’s gravity.

For lesser severity, penalties range lower: fines, restriction of liberty, or up to one year imprisonment.

The act also provides for possible discontinuation of proceedings under article 62a when the act concerns a small amount for personal use and punishment would be inappropriate due to circumstances and social harm degree. Discontinuation applies to the basic and privileged types, not the qualified type, and may occur before investigation or inquiry initiation. This is a loophole, not a guarantee, and cannot be planned in advance.

Abroad, Polish regulations do not apply. Liability is under the law of the country where inspection occurs, and sanctions may be incomparably harsher than domestic ones. Additionally, there are non-penal consequences patients rarely consider: interrupted travel, loss of medicine, thus therapy interruption in an unknown place, and a record that may complicate future entries. Given this, the cost of preparing the document in advance is disproportionately low.

What are the alternatives when transport is impossible?

Three, all requiring discussion with the attending physician before departure. The first is treatment continuation locally, the second is temporary therapy change, the third is postponing or shortening the trip. None should be chosen independently, as each involves interference with ongoing treatment.

Local continuation involves obtaining a prescription from a doctor in the destination country, in states with their own medical program. It requires checking before departure whether such a path exists and what documents are required from foreigners, as availability may be formal, not actual. It is worth asking the attending physician for an English-language extract from documentation to facilitate communication locally.

Temporary therapy change is solely a medical decision. In areas of pain, spasticity, or nausea, other pharmaceutical options exist, but their selection depends on the patient’s specific situation, and self-change carries the risk of symptom recurrence. The third option, postponing or shortening the trip to fit the document period, is often the simplest and cheapest, though it looks like a concession. For travel to countries with unclear legal status, it is usually the only reasonable option. We also develop the topic of traveling with treatment in the guide about traveling with medical marijuana.

How to behave during inspection?

Calmly and with the document in hand before any question is asked. Voluntarily declaring possession of medicine is better than waiting for it to be found, as it immediately sets the situation as legal transport, not an attempt to hide. It is worth keeping the document separately, not at the bottom of the luggage.

The regulation also imposes its own obligation. According to paragraph 10, holders of documents from paragraphs 5 and 6 transport medicinal products containing narcotics under conditions preventing access by unauthorized persons. In practice, this means medicine in the original sealed package, under the patient’s direct control, not loose in checked luggage.

It is worth agreeing on the order of showing documents before travel to avoid searching at the inspection point. First the transport document, then the prescription or medical documentation, finally the medicine package with label. If the inspection drags or there is a dispute about documents, the patient has the right to request contact with the Polish consular office, which abroad is usually the most effective step. One should not sign documents in a language they do not understand or admit to circumstances they do not know.

Frequently Asked Questions

Does legal purchase in another country protect upon entry?

No. The British Psychoactive Substances Act punishes intentional import even with the intent to use solely for oneself, though possession of the same item locally is not punishable.

How much cannabis medicine can be transported across the border?

Where a procedure exists, the limit is counted in days of therapy. Montenegro allows a supply for up to thirty days based on a doctor’s certificate, and Thailand the same for medicines not being controlled substances.

How long is the medical certificate valid for transport?

Montenegro accepts a document issued no more than 90 days earlier and requires showing it to customs. Failure to declare a veterinary document for an animal is a separate offense there with a 100 euro fine.

Is a postal shipment treated more leniently than transport in baggage?

In Lithuania, no. The smuggling provision lists transport and sending side by side, so ordering from abroad is subject to the same qualification as personally carrying the same amount.

Can one be liable for marijuana use abroad?

In Singapore, yes. A citizen or permanent resident detected using a controlled substance abroad is liable as if they used it in Singapore.

Can a past drug conviction block entry?

Yes. Indonesia closes entry to a foreigner with a past drug offense and sets no time limit.

Can a patient transport cannabis medicine to the Netherlands themselves?

The Dutch medical cannabis office holds a monopoly also on import and export, so there is no path for transport outside this office. This is silence of the regulation, not an explicit ban.

Sources

The article is informational and educational and does not constitute legal advice. The legal status described applies as of the publication date: cannabis regulations may change. Consult a lawyer or current legal acts before making decisions.

Author: Michał Waluk